Brellium

Brellium Competitive Intelligence & Landscape

brellium.com ·

Overview

Brellium Overview

Brellium is a healthcare technology company founded in 2021 and headquartered in New York, NY. The company specializes in developing an AI-powered clinical compliance platform designed to automate and streamline medical chart reviews, ensuring adherence to payor policies, regulatory requirements, and clinical standards across all 50 states (Preqin, PitchBook).

The core products of Brellium include AI-driven chart auditing, automated incident reporting, MDM & E/M coding support, clawback protection, and quality trend data, which are tailored for healthcare providers, clinics, and behavioral health organizations (Brellium). Its target market encompasses a broad range of healthcare sectors such as mental health, ABA therapy, hospice, and enterprise healthcare systems, serving organizations of various sizes from single-site clinics to large enterprise operations (Brellium).

Brellium's mission is to improve healthcare quality and compliance by leveraging AI to reduce manual audit workloads, lower compliance risks, and enhance documentation accuracy. Backed by venture capital and with a team of around 75 employees, the company aims to transform healthcare compliance processes and support providers in delivering higher standards of care (Brellium). Its value proposition centers on automating complex compliance tasks, reducing costs, and proactively identifying documentation errors to ensure regulatory and payer standards are consistently met.

Brellium

Brellium Weekly Intel Updates

Receive weekly intel updates about Brellium straight to your inbox.

Competitors

Brellium Competitors

AuditBoard is a leading competitor to Brellium, primarily positioned in the audit and compliance automation market. It offers comprehensive solutions for internal audit, risk management, and compliance, with a strong focus on enterprise clients. AuditBoard's key differentiator is its extensive suite of audit management tools, which are highly customizable and integrated, making it popular among large organizations (The Company Check). In comparison, Brellium specializes in AI-powered auditing solutions for healthcare, emphasizing clinical compliance and analytics, which gives it a niche market edge (The Company Check). Pricing details are typically tailored to enterprise needs, but AuditBoard's solutions are generally considered premium, reflecting its market share dominance in large-scale audit management (SaaSipedia).

Ocrolus is a fintech-focused competitor offering document processing and data automation solutions. Its key strength lies in its AI-driven document analysis, which automates financial document review processes for banks, lenders, and accounting firms (The Company Check). Unlike Brellium, which targets healthcare and compliance, Ocrolus's market positioning is centered on financial data automation, making it a strong player in fintech automation markets. Its pricing model is subscription-based, often more affordable for small to mid-sized firms, and it holds a significant share in financial document processing (Skima.ai).

Auditoria.AI is an AI-driven audit platform focusing on automating internal audit processes with a strong emphasis on data analytics and real-time insights. Its differentiator is its advanced AI algorithms that enable predictive analytics and continuous auditing, appealing to enterprise clients seeking proactive risk management (The Company Check). Compared to Brellium's healthcare niche, Auditoria.AI targets broader industries with a focus on internal controls and operational audits. Pricing is typically subscription-based, with enterprise-tier options that compete directly with Brellium’s offerings (SaaSipedia).

Caseware offers audit, financial reporting, and compliance solutions with a strong presence in accounting firms and enterprise finance departments. Its key differentiator is its robust audit software that supports complex financial audits and regulatory compliance, emphasizing accuracy and scalability (The Company Check). Market positioning is more traditional compared to Brellium’s AI-driven approach, but it holds a significant market share in audit software for accounting firms. Pricing is often subscription-based, tailored to firm size and scope, making it competitive in the enterprise audit market (SaaSipedia).

Product & Pricing

Brellium Product and Pricing Intelligence

Brellium offers a comprehensive AI-powered clinical compliance platform designed to streamline documentation audits, coding, and payor support for healthcare providers. As of March 2026, Brellium's product suite includes features such as AI chart auditing, MDM & E/M coding, clawback protection, and automated provider training, serving a variety of healthcare sectors including ABA therapy, mental health, and hospice (brellium.com).

Regarding pricing, Brellium provides multiple subscription plans tailored to different organizational sizes and needs. The plans include a Starter tier at $69 per month, suitable for individuals or small practices, and more advanced options like Pro at $110 per month and Pro Team at $190 per month, which offer additional users, storage, and API capabilities. All plans come with a 30-day free trial, allowing users to test features before committing (brillium.com/pricing).

While specific recent pricing changes are not detailed in the available sources, the tiered structure and free trial offer flexibility for various practice sizes, from single-site providers to enterprise organizations. Brellium emphasizes scalable solutions with optional add-ons such as live support and integrations, making it adaptable to evolving compliance and documentation needs (elion.health). This pricing approach reflects Brellium’s focus on providing accessible, high-quality compliance tools for healthcare providers in 2026.

Ad Campaigns

Brellium Ad Campaigns

Brellium is currently running 153 ads across Google, LinkedIn — 25 on Google and 128 on LinkedIn. Explore Brellium's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Brellium's ads

View ads

Hiring & Layoffs

Brellium Hiring and Layoffs

Brellium is a healthcare technology company founded in 2021, focused on using AI to automate chart review and improve clinical compliance [4]. The company has experienced significant growth, with a reported 116.7% year-over-year employee increase, bringing their total to 65 employees as of the latest data [4]. This rapid expansion is supported by substantial funding, including a Series A round of $16.7 million in April 2025, bringing their total funding to over $27.8 million [4].

Brellium's mission is to enhance healthcare quality and safety by providing AI-powered tools that help providers mitigate risks and ensure adherence to clinical and payer requirements [5].

Recent hiring trends at Brellium indicate a focus on growth and development within key areas of their AI-powered platform. Notable job openings include a Software Engineer - AI position, highlighting their commitment to advancing their core technology [2]. Additionally, they have advertised for a Head of People, a role crucial for managing and scaling their growing workforce [5]. The company's emphasis on hiring for these roles suggests a strategy centered on technological innovation and robust human capital management to achieve their ambitious goals in transforming healthcare compliance [5].

While the provided search results do not indicate any layoffs at Brellium, their consistent hiring and significant year-over-year employee growth suggest an aggressive expansion strategy [4]. The company's focus on AI in healthcare compliance, a field with increasing demand for efficiency and accuracy, positions them for continued development.

Brellium's hiring patterns signal a company actively investing in its technological capabilities and team to solidify its market position and scale its AI-driven solutions for healthcare providers [2, 5].

Leadership

Brellium Management and Leadership Team

The leadership team at Brellium is headed by Zach Rosen, who serves as the Co-Founder and CEO of the company. Rosen has been instrumental in leading Brellium’s efforts to develop AI-powered solutions for clinical compliance and chart review automation, with his role confirmed as of late 2024 (The Org).

Recent leadership updates include the addition of Dr. Ainsley MacLean, FACR, who joined as a strategic advisor in February 2026, bringing extensive experience in AI-enhanced clinical decision support, particularly from her work at Kaiser Permanente (Business Wire). This appointment signifies Brellium’s focus on strengthening its clinical expertise and AI capabilities.

The management team also includes key executives such as Olin Wakkary, the Head of Customer Success, and Max Katzman, the Head of Engineering, both of whom are vital for operational growth and technological development. The company's board members and other notable hires at the C-suite level are not explicitly detailed in the current sources, but the leadership appears focused on expanding its AI platform for healthcare compliance and chart auditing solutions (RocketReach).

Financials

Brellium Financial Performance, Fundraising, M&A

Brellium has demonstrated significant growth and activity in the healthcare AI sector, with notable funding rounds and revenue achievements. In April 2025, Brellium raised $16.7 million to develop its AI-powered clinical compliance platform, reflecting strong investor confidence in its technology and market potential (Fierce Healthcare). Prior to this, the company secured $11.1 million in funding from investors, indicating ongoing financial backing and valuation growth (Tracxn).

Financially, Brellium reported a revenue of $6.4 million in 2025, achieved with a team of 46 employees, showcasing its operational scale and market traction (GetLatka). The company’s valuation is estimated to be at Series B stage as of 2023, based in New York City, and focused on AI solutions for healthcare compliance and auditing (Tracxn). Additionally, Brellium has engaged in M&A activity, though specific acquisitions are not detailed in the available sources. Overall, Brellium’s financial health appears robust, driven by continuous funding, revenue growth, and strategic product development in healthcare AI (Fierce Healthcare).

Partnerships

Brellium Partnerships, Clients and Vendors

Brellium has established a robust ecosystem through strategic partnerships, enterprise clients, and technology integrations that enhance healthcare compliance and revenue cycle management. The company collaborates with various vendors across clinical, billing, compliance, credentialing, and quality assurance sectors, including notable partners like BillingParadise, Therapy Management Solutions, and Silna Health, which support services such as revenue cycle management, ABA provider billing, and prior authorization processes (source).

Brellium’s enterprise client base includes over 100,000 providers, mental health organizations, and behavioral health agencies, demonstrating its extensive reach within the healthcare industry (source). Its clients span specialties like ABA therapy, mental health, hospice, and substance use treatment, with many organizations leveraging Brellium’s AI-powered auditing and compliance tools to improve documentation quality and ensure regulatory adherence (source).

The company’s technology ecosystem is centered around AI-driven solutions such as chart auditing, MDM & E/M coding, and payor support, which are integrated into healthcare workflows to automate compliance and reduce administrative burdens (source). Brellium’s partnerships extend into the digital health space, with collaborations aimed at supporting large multi-site enterprises and digital health providers, further solidifying its position as a key player in healthcare compliance and revenue optimization (source). As of 2026, Brellium continues to expand its ecosystem through funding, strategic alliances, and a growing network of preferred vendors and industry-specific partners, reinforcing its mission to elevate healthcare quality and efficiency (source).

Events

Brellium Event Participations

Brellium actively participates in various industry events, including webinars, conferences, and community events, to promote its AI-powered clinical compliance platform. Notably, they host webinars focused on healthcare innovation and AI trends, where they discuss topics such as healthcare technology, compliance, and quality improvement strategies (brellium.com). These webinars serve as a platform for engaging with healthcare providers, clinical directors, and compliance officers, and are frequently updated to reflect current industry trends (brellium.com).

While specific details about conferences, trade shows, or community sponsorships are not explicitly listed in the search results, Brellium’s active online presence through webinars and resource sharing indicates ongoing engagement in educational and industry events. They also participate in community and industry discussions through their resource pages and case studies, which help establish thought leadership in healthcare compliance and AI technology (brellium.com). As of March 2026, Brellium’s focus remains on leveraging webinars and digital events to connect with healthcare professionals and promote their solutions.

Frequently Asked Questions

What does Brellium's 116.7% year-over-year headcount growth signal about where they are in their scaling cycle?

Brellium's 116.7% year-over-year employee growth — reaching approximately 65–75 employees — indicates a company in aggressive early-scale mode, not yet in efficiency optimization. This aligns with their April 2025 Series A of $16.7 million (total funding over $27.8 million), which appears to be funding a deliberate hiring push rather than a mature, revenue-led expansion. At $6.4 million in reported 2025 revenue with 46 employees at the time of measurement, the revenue-per-employee ratio suggests they are investing ahead of revenue, a common Series A pattern in vertical SaaS.

What does Brellium's decision to open a Head of People role signal about their organizational priorities post-Series A?

Hiring a Head of People at this stage signals that Brellium has hit the inflection point where informal people operations can no longer support its hiring pace. With headcount more than doubling year-over-year, the role is almost certainly being created to build out structured recruiting, onboarding, and retention functions rather than to manage a static workforce. This is a common precursor to a second hiring surge, suggesting Brellium expects to continue scaling its team materially through 2025 and 2026 on the back of its Series A capital.

Does Brellium's $6.4M revenue figure against $27.8M in total funding suggest a capital-efficient trajectory or a burn concern?

At $6.4 million in 2025 revenue against $27.8 million in total funding, Brellium's capital-to-revenue ratio is elevated but not unusual for a vertical AI SaaS company at Series A stage targeting a compliance-heavy, sales-intensive healthcare market. The more meaningful signal is whether ARR is growing rapidly enough to close that gap; the 116% headcount expansion and the fresh $16.7 million raise in April 2025 imply investors are betting on an accelerating revenue trajectory rather than flagging a burn problem. ForesightIQ continues to monitor Brellium's revenue and headcount metrics for signs of efficiency improvement as the Series A capital is deployed.

What does the addition of Dr. Ainsley MacLean as a strategic advisor reveal about Brellium's product or market ambitions?

Dr. MacLean's appointment in February 2026, with her background in AI-enhanced clinical decision support from Kaiser Permanente, signals that Brellium is moving to deepen the clinical credibility of its AI platform — not just its compliance automation. This advisory hire is particularly meaningful because enterprise health systems and large payers scrutinize the clinical validity of AI-driven audit tools; having a FACR-credentialed physician with enterprise health system experience on board directly addresses that procurement objection. It also hints at potential product expansion toward clinical decision support use cases beyond the current chart-audit and coding focus.

How does Brellium's vertical focus on behavioral health and ABA therapy differentiate it from broader audit automation competitors like AuditBoard or Auditoria.AI?

Brellium occupies a defensible niche by targeting behavioral health, ABA therapy, mental health, hospice, and substance use treatment — sectors with highly specific payer requirements and documentation standards that general-purpose audit platforms like AuditBoard or Auditoria.AI are not configured to handle out of the box. AuditBoard and Auditoria.AI primarily serve enterprise internal audit and financial compliance functions across industries, while Brellium's value proposition is built around clinical chart auditing, clawback protection, and payor-specific policy adherence across all 50 states. This specialization raises switching costs for Brellium's customers and makes direct competitive displacement by horizontal players difficult without significant customization investment.

What does Brellium's partner ecosystem — including BillingParadise, Therapy Management Solutions, and Silna Health — reveal about its go-to-market motion?

Brellium's preferred vendor network is concentrated in revenue cycle management, ABA billing, and prior authorization services, which indicates a channel-driven go-to-market strategy that piggybacks on existing operational relationships healthcare providers already have. By embedding alongside billing and credentialing partners, Brellium can reach compliance decision-makers through trusted intermediaries rather than relying solely on direct enterprise sales — a capital-efficient approach for a company at its stage. This partner structure also suggests Brellium is positioning its AI audit tool as a complement to, rather than a replacement of, the broader administrative services stack these partners already sell.

What does Brellium's webinar-heavy event strategy suggest about the maturity of its demand generation function?

Brellium's reliance on owned webinars and digital content rather than major trade show presence indicates a demand generation function that is still in its early build-out phase, prioritizing low-cost thought leadership over high-cost field marketing. This is consistent with a ~65-person company that has not yet reached the scale to justify large conference sponsorship budgets. The webinar focus on clinical directors and compliance officers is strategically sound for reaching Brellium's buyer persona, but it will become a constraint on pipeline velocity as the company scales, suggesting a transition to field sales and conference investment is likely on the 2026–2027 roadmap as Series A capital is deployed.

Is Brellium's Software Engineer – AI hiring a signal of building proprietary models or integrating existing LLM infrastructure?

The job title 'Software Engineer – AI' is broad enough to encompass either direction, but at Brellium's current size and funding level, building proprietary clinical foundation models would be capital-prohibitive; the more likely interpretation is that this role is focused on fine-tuning, prompt engineering, and workflow integration on top of existing large language model infrastructure applied to chart review and coding tasks. This is the standard architecture for vertical AI SaaS companies at Series A, where the defensibility comes from domain-specific training data and workflow integration rather than underlying model development. The hire nonetheless signals that AI capability is being treated as a core engineering function, not a vendor dependency.

What does Brellium's claim of serving over 100,000 providers suggest about its actual enterprise penetration versus individual provider reach?

The '100,000 providers' figure most likely reflects the cumulative count of individual clinicians within Brellium's enterprise and multi-site organizational clients, not 100,000 independently contracted accounts — a common and legitimate way for B2B healthcare platforms to quantify reach. With a team of 65–75 employees, Brellium could not plausibly maintain direct relationships with 100,000 discrete customer accounts. The more strategically relevant signal is that Brellium has penetrated enough multi-site behavioral health organizations and enterprise healthcare systems to aggregate that provider count, which implies its sales motion is concentrated on high-ACV organizational contracts rather than a long-tail of small practices.

What does Brellium's product coverage across all 50 states for payer policy compliance signal about its data infrastructure investment?

Maintaining AI-driven payer policy compliance across all 50 states requires continuous ingestion and updating of state-specific Medicaid rules, commercial payer policies, and regulatory requirements — a significant ongoing data operations investment that constitutes a meaningful barrier to competitive replication. This breadth is a core differentiator Brellium is building into its platform, and it also increases customer switching costs because migrating to a competitor would require that competitor to match the same policy coverage depth. It suggests Brellium is investing materially in data curation and policy mapping as a moat, not just in the AI inference layer.

What is the strategic implication of Brellium's clawback protection product feature for its positioning in the revenue cycle management market?

Clawback protection — helping providers defend against payer demands to return previously paid claims — positions Brellium as a revenue-preservation tool with a quantifiable, near-term ROI, not just a compliance cost center. This framing is strategically important because it shifts the budget conversation from a compliance department line item to a revenue cycle or CFO-level priority, which typically unlocks larger contract values and faster procurement decisions. It also creates a natural expansion opportunity into adjacent revenue cycle management workflows, and likely explains the partnership relationships Brellium has cultivated with RCM vendors like BillingParadise.

Does Brellium's April 2025 Series A position it for a near-term Series B, and what milestones would likely trigger that raise?

With $16.7 million raised in April 2025 and $6.4 million in reported 2025 revenue, Brellium would likely need to demonstrate ARR in the $15–25 million range and a clear path to sustained growth before attracting a competitive Series B at a meaningful step-up valuation. The 116% headcount growth funded by the Series A suggests an 18–24 month runway deployment cycle targeting precisely that revenue scale, which would put a potential Series B raise in the 2026–2027 window. The addition of a clinically credentialed strategic advisor and the hiring of a Head of People are both signals consistent with a company actively preparing its narrative and organizational infrastructure for the next fundraising cycle.

Powered by ForesightIQ · Competitive intelligence from digital exhaust